Additional S1 chemotherapy for patients underwent non curative ESD for gastric cancer:exploratory clinical trial

Not Applicable

• Conditions: gastric cancer

• Registration Number: JPRN-UMIN000038357
• Lead Sponsor: Takatsuki general hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-23
• Last Update Posted: 20 November 2023
• Study Completion: 2026-09-30

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

Not provided

Exclusion Criteria

1)Synchronous double/multiple cancer or metachronous double/multiple cancer with progression free period of 5 years or shoter, except mucosal cancer treated by endoscopic resection 2) previous gastrectomy 3) Infection requiring systemic treatment 4) Women expecting pregnancy, in pregnancy, in possible pregnancy or in breast feeding 5) Male expecting partner's pregnancy 6) Severe mental disease 7) Under treatment by flucytosine, phenytoin, or warfarin potassium 8) Uncontrolled diabetes mellitus 9) severe lung disease (Interstitial pneumonia, severe emphysema and so on) 10) unstable angina or myocardial infarction within 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified